+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Small Molecule Drug"

From
From
From
From
From
From
From
Growth Indicators for Technology-enabled Drug Discovery - Product Thumbnail Image

Growth Indicators for Technology-enabled Drug Discovery

  • Report
  • June 2023
  • 77 Pages
  • Global
From
Global Orphan Drug Growth Opportunities - Product Thumbnail Image

Global Orphan Drug Growth Opportunities

  • Report
  • March 2024
  • 78 Pages
  • Global
From
From
From
Metastatic Breast Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Metastatic Breast Cancer Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
DB102 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

DB102 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
VX-121 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

VX-121 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
From
From
From
Loading Indicator

The Small Molecule Drug market is a segment of the Pharmaceuticals industry that focuses on the development and production of drugs composed of small molecules. These drugs are typically used to treat a wide range of diseases, including cancer, diabetes, and cardiovascular diseases. Small molecule drugs are typically taken orally, and are designed to target specific areas of the body. The Small Molecule Drug market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of small molecule drugs, as well as the marketing and distribution of these drugs. Show Less Read more